Pri-Med Phoenix | Cactus

Thursday−Friday, May 9–10|Phoenix, AZ

Pri-Med Phoenix | Regional CME/CE Conference

Thursday, May 9 2024

12:30–1:45pm

CME/CE

P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)

South Ballroom

Description

The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

The session: P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain: Part 1 (1.25 hours) is designed to satisfy state licensure requirements related to opioid, substance use disorder or addiction for Arizona (MD/DO/PA/NP), as well as training requirements for the DEA MATE Act.

Learning Objectives

  • Discuss the definitions and mechanisms of pain
  • Identify risk factors and stratification for opioid-related aberrant behavior and opioid use disorder as part of the initial assessment
  • Apply individualized recommendations for nonpharmacologic and non-opioid treatment options for patients in pain

Faculty

Educational Partner

  • Miller Medical Communications, LLC

Commercial Supporter

  • Opioid Analgesic REMS Program Companies